Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: A registry study

Lung Cancer

Volumn 83, Issue 3, 2014, Pages 347-355

  Rasmussen, Jakob F ^a   Siersma, Volkert ^a   Pedersen, Jesper H ^a   Heleno, Bruno ^a   Saghir, Zaigham ^a   Brodersen, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cancer early detection; Cancer screening test; Healthcare cost; Lung cancer; Mass screening; Scan spiral CT

Indexed keywords

CANCER EARLY DETECTION; CANCER SCREENING TEST; HEALTHCARE COST; LUNG CANCER; MASS SCREENING; SCAN SPIRAL CT;

AGED; DENMARK; EARLY DETECTION OF CANCER; FEMALE; HEALTH CARE COSTS; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; REGISTRIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84894226834     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.12.005     Document Type: Article

References (25)

1. Ott J.J., Ullrich A., Mascarenhas M., Stevens G.A. Global cancer incidence and mortality caused by behavior and infection. J Public Health (Oxf) 2011, 33(June (2)):223-233.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(January (1)):10-29.
3. Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365(August (5)):395-409.
4. Becker N., Motsch E., Gross M.L., Eigentopf A., Heussel C.P., Dienemann H., et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 2012, 138(September (9)):1475-1486.
5. Field J.K., Van K.R., Pedersen J.H., Pastorino U., Paci E., Becker N., et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013, (July). 10.1002/jso.23383.
6. Infante M., Cavuto S., Lutman F.R., Brambilla G., Chiesa G., Ceresoli G., et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009, 180(September (5)):445-453.
7. Lopes P.A., Picozzi G., Mascalchi M., Maria C.F., Carrozzi L., Comin C., et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009, 64(April (1)):34-40.
8. Pastorino U., Rossi M., Rosato V., Marchiano A., Sverzellati N., Morosi C., et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012, 21(May (3)):308-315.
9. Saghir Z., Dirksen A., Ashraf H., Bach K.S., Brodersen J., Clementsen P.F., et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012, 67(April (4)):296-301.
10. Van Iersel C.A., de Koning H.J., Draisma G., Mali W.P., Scholten E.T., Nackaerts K., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120(February (4)):868-874.
11. Manser R., Lethaby A., Irving L.B., Stone C., Byrnes G., Abramson M.J., et al. Screening for lung cancer. Cochrane Database Syst Rev 2013, 6. 10.1002/14651858.CD001991.pub3.
12. Goulart B.H., Bensink M.E., Mummy D.G., Ramsey S.D. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw 2012, 10(February (2)):267-275.
13. Van Klaveren R.J., Oudkerk M., Prokop M., Scholten E.T., Nackaerts K., Vernhout R., et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009, 361(December (23)):2221-2229.
14. Barton M.B., Moore S., Polk S., Shtatland E., Elmore J.G., Fletcher S.W. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med 2001, 16(March (3)):150-156.
15. Lafata J.E., Simpkins J., Lamerato L., Poisson L., Divine G., Johnson C.C. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev 2004, 13(December (12)):2126-2132.
16. Lidbrink E., Elfving J., Frisell J., Jonsson E. Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. BMJ 1996, 312(February (7026)):273-276.
17. Brodersen J., Siersma V. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 2013, 11(2):106-115.
18. Pedersen J.H., Ashraf H., Dirksen A., Bach K., Hansen H., Toennesen P., et al. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round. J Thorac Oncol 2009, 4(May (5)):608-614.
19. Brodersen J., Thorsen H., Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health 2010, 13(August (5)):601-612.
20. Diehr P., Yanez D., Ash A., Hornbrook M., Lin D.Y. Methods for analyzing health care utilization and costs. Annu Rev Public Health 1999, 20:125-144.
21. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004, 159(April (7)):702-706.
22. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57(January (1)):289-300.
23. Brodersen J., Siersma V., Ryle M. Breast cancer screening: "reassuring" the worried well?. Scand J Public Health 2011, 39(May (3)):326-332.
24. Saghir Z., Ashraf H., Dirksen A., Brodersen J., Pedersen J.H. Contamination during 4 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST). Lung Cancer 2011, 71(March (3)):323-327.
25. Villanti A.C., Jiang Y., Abrams D.B., Pyenson B.S. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS ONE 2013, 8(8):e71379.